Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Autoimmune Diseases × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 10 Spondylitis, Ankylosing 4 Psoriasis 3 Crohn Disease 3 Colitis, Ulcerative 2 Uveal Melanoma 1 Thyroid Carcinoma, Anaplastic 1 Spondylarthritis 1 Sarcoidosis 1 Plaque Psoriasis 1 Osteoarthritis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Melanoma 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Joint Diseases 1 Inflammatory Bowel Diseases 1 Inflammation 1 Healthy Adult Male 1 Healthy 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Autoimmune Diseases 1 Arthritis 1

Interventions

telitacicept 3 fludarabine 3 Prednisone 3 Cyclophosphamide 3 Specimen Handling 2 Nivolumab 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Vitamin D 1 Valsartan 1 Pyridostigmine Bromide 1 Population Groups 1 Plasma Exchange 1 Peripheral Blood Stem Cell Transplantation 1 Music Therapy 1 Melphalan 1 Infliximab 1 Immunoglobulins, Intravenous 1 Hydroxychloroquine 1 Fish Oils 1 Fatty Acids, Omega-3 1 Etoposide 1 Etanercept 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡